Shalini Sharp - 21 May 2025 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role: Director
Signature: /s/ Qing Nian, as Attorney-in-Fact
Issuer symbol: BGNE
Transactions as of: 21 May 2025
Transactions value $: $0
Form type: 4
Filing time: 22 May 2025, 19:47:00 UTC
Previous filing: 24 Oct 2024
Next filing: 16 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sharp Shalini	Director	C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVE, CAMANA BAY, GRAND CAYMAN, CAYMAN ISLANDS	/s/ Qing Nian, as Attorney-in-Fact	22 May 2025	0001377202

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BGNE	Ordinary Shares	Award	$0	+11K	+134.77%	$0.00	19.1K	21 May 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BGNE	Share Option (Right to Buy)	Award	$0	+22.8K		$0.00	22.8K	21 May 2025	Ordinary Shares	22.8K	$18.19	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents securities underlying restricted share units. The restricted share units shall become fully vested on the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the director resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The restricted share units were granted under the Company's Independent Director Compensation Policy, as amended.
F2	The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.
F3	The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events. The option was granted under the Company's Independent Director Compensation Policy, as amended.